Efficacy and Safety of MLC601 (NeuroAiD®), a Traditional Chinese Medicine, in Poststroke Recovery: A Systematic Review | Zendy

Fahad Javaid Siddiqui | Zendy; Narayanaswamy Venketasubramanian | Zendy; Edwin Chan | Zendy; Christopher Chen | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Efficacy and Safety of MLC601 (NeuroAiD®), a Traditional Chinese Medicine, in Poststroke Recovery: A Systematic Review

Author(s) -

Fahad Javaid Siddiqui,

Narayanaswamy Venketasubramanian,

Edwin Chan,

Christopher Chen

Publication year - 2013

Publication title -

cerebrovascular diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.221

H-Index - 104

eISSN - 1421-9786

pISSN - 1015-9770

DOI - 10.1159/000346231

Subject(s) - medicine , stroke (engine) , meta analysis , data extraction , randomized controlled trial , physical therapy , cochrane library , medline , placebo , adverse effect , clinical trial , physical medicine and rehabilitation , intensive care medicine , alternative medicine , pathology , mechanical engineering , political science , law , engineering

Subsequent to a pooled analysis of 2 trials, several more studies have been published assessing the benefit of MLC601 in stroke patients. Hence, it is timely to conduct an updated meta-analysis to frame the interpretation of the results of an ongoing large multicenter, randomized, double-blind, placebo-controlled study. Therefore, we conducted a systematic review of the efficacy of MLC601 in improving the recovery of stroke patients.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research